Sunitinib Malate 50mg

Sunitinib, sold under the brand name Sutent, is a medication used to treat cancer. It is a small-molecule, multi-targeted receptor tyrosine kinase inhibitor that was approved by the FDA for the treatment of renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications.

Specification/Additional Details

• Packaging Size – 1X7
• Brand – Sutent
• Composition – Sunitinib
• Manufacturer – Pfizer
• Treatment – gastrointestinal stromal tumor (GIST) and advanced renal cell carcinoma (RCC)
• Prescription/Non prescription